David A. Siegel Ginkgo Bioworks Holdings, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 31,443,550 shares of DNA stock, worth $275 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
31,443,550
Previous 1,131,043
2680.05%
Holding current value
$275 Million
Previous $1.31 Million
690.85%
% of portfolio
0.02%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DNA
# of Institutions
209Shares Held
716MCall Options Held
990KPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.25 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.22 Billion0.0% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$612 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$368 Million0.0% of portfolio
-
Legal & General Group PLC London, X027MShares$237 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $11.3B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...